222 related articles for article (PubMed ID: 30111575)
1. The D' domain of von Willebrand factor requires the presence of the D3 domain for optimal factor VIII binding.
Przeradzka MA; Meems H; van der Zwaan C; Ebberink EHTM; van den Biggelaar M; Mertens K; Meijer AB
Biochem J; 2018 Sep; 475(17):2819-2830. PubMed ID: 30111575
[TBL] [Abstract][Full Text] [Related]
2. The von Willebrand factor D'D3 assembly and structural principles for factor VIII binding and concatemer biogenesis.
Dong X; Leksa NC; Chhabra ES; Arndt JW; Lu Q; Knockenhauer KE; Peters RT; Springer TA
Blood; 2019 Apr; 133(14):1523-1533. PubMed ID: 30642920
[TBL] [Abstract][Full Text] [Related]
3. Two novel mutations, Q1053H and C1060R, located in the D3 domain of von Willebrand factor, are responsible for decreased FVIII-binding capacity.
Hilbert L; Jorieux S; Proulle V; Favier R; Goudemand J; Parquet A; Meyer D; Fressinaud E; Mazurier C;
Br J Haematol; 2003 Feb; 120(4):627-32. PubMed ID: 12588349
[TBL] [Abstract][Full Text] [Related]
4. Solution structure of the major factor VIII binding region on von Willebrand factor.
Shiltagh N; Kirkpatrick J; Cabrita LD; McKinnon TA; Thalassinos K; Tuddenham EG; Hansen DF
Blood; 2014 Jun; 123(26):4143-51. PubMed ID: 24700780
[TBL] [Abstract][Full Text] [Related]
5. Recessive von Willebrand disease type 2 Normandy: variable expression of mild hemophilia and VWD type 1.
Michiels JJ; Gadisseur A; Vangenegten I; Schroyens W; Berneman Z
Acta Haematol; 2009; 121(2-3):119-27. PubMed ID: 19506358
[TBL] [Abstract][Full Text] [Related]
6. D' domain region Arg782-Cys799 of von Willebrand factor contributes to factor VIII binding.
Przeradzka MA; van Galen J; Ebberink EHTM; Hoogendijk AJ; van der Zwaan C; Mertens K; van den Biggelaar M; Meijer AB
Haematologica; 2020 Jun; 105(6):1695-1703. PubMed ID: 31558672
[TBL] [Abstract][Full Text] [Related]
7. A novel mutation in the D3 domain of von Willebrand factor markedly decreases its ability to bind factor VIII and affects its multimerization.
Jorieux S; Gaucher C; Goudemand J; Mazurier C
Blood; 1998 Dec; 92(12):4663-70. PubMed ID: 9845532
[TBL] [Abstract][Full Text] [Related]
8. Molecular genetics of type 2 von Willebrand disease.
Fressinaud E; Mazurier C; Meyer D
Int J Hematol; 2002 Jan; 75(1):9-18. PubMed ID: 11843298
[TBL] [Abstract][Full Text] [Related]
9. Abnormal von Willebrand factor secretion, factor VIII stabilization and thrombus dynamics in type 2N von Willebrand disease mice.
Swystun LL; Georgescu I; Mewburn J; Deforest M; Nesbitt K; Hebert K; Dwyer C; Brown C; Notley C; Lillicrap D
J Thromb Haemost; 2017 Aug; 15(8):1607-1619. PubMed ID: 28581694
[TBL] [Abstract][Full Text] [Related]
10. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
[TBL] [Abstract][Full Text] [Related]
11. Laboratory diagnosis and molecular classification of von Willebrand disease.
Gadisseur A; Hermans C; Berneman Z; Schroyens W; Deckmyn H; Michiels JJ
Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
[TBL] [Abstract][Full Text] [Related]
12. Visualization of an N-terminal fragment of von Willebrand factor in complex with factor VIII.
Yee A; Oleskie AN; Dosey AM; Kretz CA; Gildersleeve RD; Dutta S; Su M; Ginsburg D; Skiniotis G
Blood; 2015 Aug; 126(8):939-42. PubMed ID: 26065653
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of von Willebrand disease type 2N: a simplified method for measurement of factor VIII binding to von Willebrand factor.
Miller CH; Kelley L; Green D
Am J Hematol; 1998 Aug; 58(4):311-8. PubMed ID: 9692396
[TBL] [Abstract][Full Text] [Related]
14. Type 2N von Willebrand disease due to compound heterozygosity for R854Q and a novel R763G mutation at the cleavage site of von Willebrand factor propeptide.
Hilbert L; Nurden P; Caron C; Nurden AT; Goudemand J; Meyer D; Fressinaud E; Mazurier C;
Thromb Haemost; 2006 Sep; 96(3):290-4. PubMed ID: 16953269
[TBL] [Abstract][Full Text] [Related]
15. Conformational changes in the D' domain of von Willebrand factor induced by CYS 25 and CYS 95 mutations lead to factor VIII binding defect and multimeric impairment.
Jorieux S; Fressinaud E; Goudemand J; Gaucher C; Meyer D; Mazurier C
Blood; 2000 May; 95(10):3139-45. PubMed ID: 10807780
[TBL] [Abstract][Full Text] [Related]
16. The mutation Arg (53)----Trp causes von Willebrand disease Normandy by abolishing binding to factor VIII. Studies with recombinant von Willebrand factor.
Jorieux S; Tuley EA; Gaucher C; Mazurier C; Sadler JE
Blood; 1992 Feb; 79(3):563-7. PubMed ID: 1732004
[TBL] [Abstract][Full Text] [Related]
17. Expression of two type 2N von Willebrand disease mutations identified in exon 18 of von Willebrand factor gene.
Hilbert L; Jorieux S; Fontenay-Roupie M; Guicheteau M; Fressinaud E; Meyer D; Mazurier C;
Br J Haematol; 2004 Oct; 127(2):184-9. PubMed ID: 15461624
[TBL] [Abstract][Full Text] [Related]
18. Factor VIII-von Willebrand factor binding defects in autosomal recessive von Willebrand disease type Normandy and in mild hemophilia A. New insights into factor VIII-von Willebrand factor interactions.
Jacquemin M
Acta Haematol; 2009; 121(2-3):102-5. PubMed ID: 19506355
[TBL] [Abstract][Full Text] [Related]
19. Interaction Between the a3 Region of Factor VIII and the TIL'E' Domains of the von Willebrand Factor.
Dagil L; Troelsen KS; Bolt G; Thim L; Wu B; Zhao X; Tuddenham EGD; Nielsen TE; Tanner DA; Faber JH; Breinholt J; Rasmussen JE; Hansen DF
Biophys J; 2019 Aug; 117(3):479-489. PubMed ID: 31349985
[TBL] [Abstract][Full Text] [Related]
20. Molecular determinants of the factor VIII/von Willebrand factor complex revealed by BIVV001 cryo-electron microscopy.
Fuller JR; Knockenhauer KE; Leksa NC; Peters RT; Batchelor JD
Blood; 2021 May; 137(21):2970-2980. PubMed ID: 33569592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
